Supplemental Evidence and Data Request on Healthcare Industry Waste and Lifecycle Assessment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Healthcare Industry Waste and Lifecycle Assessment, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 188 (Friday, September 29, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67294-67295]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-21481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Healthcare Industry
Waste and Lifecycle Assessment
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submissions.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review on Healthcare
Industry Waste and Lifecycle Assessment, which is currently being
conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program.
Access to published and unpublished pertinent scientific information
will improve the quality of this review.
DATES: Submission Deadline on or before October 30, 2023.
ADDRESSES:
Email submissions: <a href="/cdn-cgi/l/email-protection#2346534063424b51520d4b4b500d444c55"><span class="__cf_email__" data-cfemail="f2978291b2939a8083dc9a9a81dc959d84">[email protected]</span></a>.
Print submissions:
Mailing Address: Center for Evidence and Practice Improvement,
Agency for Healthcare Research and Quality, ATTN: EPC SEADs
Coordinator, 5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857.
Shipping Address (FedEx, UPS, etc.): Center for Evidence and
Practice Improvement, Agency for Healthcare Research and Quality, ATTN:
EPC SEADs Coordinator, 5600 Fishers Lane, Mail Stop 06E77D, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: Kelly Carper, Telephone: 301-427-1656
or Email: <a href="/cdn-cgi/l/email-protection#0a6f7a694a6b62787b24626279246d657c"><span class="__cf_email__" data-cfemail="6c091c0f2c0d041e1d4204041f420b031a">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Healthcare Industry
Waste and Lifecycle Assessment. AHRQ is conducting this review pursuant
to section 902 of the Public Health Service Act, 42 U.S.C. 299a.
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Healthcare Industry Waste and Lifecycle Assessment. The
entire research protocol is available online at: <a href="https://effectivehealthcare.ahrq.gov/products/lifecycle-assessment">https://effectivehealthcare.ahrq.gov/products/lifecycle-assessment</a>.
This is to notify the public that the EPC Program would find the
following information on Healthcare Industry Waste and Lifecycle
Assessment helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this topic. In the list, please indicate whether results
are available on <a href="http://ClinicalTrials.gov">ClinicalTrials.gov</a> along with the <a href="http://ClinicalTrials.gov">ClinicalTrials.gov</a>
trial number.
[ssquf] For completed studies that do not have results on
<a href="http://ClinicalTrials.gov">ClinicalTrials.gov</a>, a summary, including the following elements, if
relevant: study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this topic. In the list, please provide the
<a href="http://ClinicalTrials.gov">ClinicalTrials.gov</a> trial number or, if the trial is not registered, the
protocol for the study including, if relevant, a study number, the
study period, design, methodology, indication and diagnosis, proper use
instructions, inclusion and exclusion criteria, and primary and
secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this topic and an index
[[Page 67295]]
outlining the relevant information in each submitted file.
Your contribution is very beneficial to the Program. Materials
submitted must be publicly available or able to be made public.
Materials that are considered confidential; marketing materials; study
types not included in the review; or information on topics not included
in the review cannot be used by the EPC Program. This is a voluntary
request for information, and all costs for complying with this request
must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program
website and available for public comment for a period of 4 weeks. If
you would like to be notified when the draft is posted, please sign up
for the email list at: <a href="https://www.effectivehealthcare.ahrq.gov/email-updates">https://www.effectivehealthcare.ahrq.gov/email-updates</a>.
The review will answer the following questions. This information is
provided as background. AHRQ is not requesting that the public provide
answers to these questions.
Guiding Questions (GQ)
GQ1. Frameworks for Life Cycle Assessment (LCA)
<bullet> What LCA frameworks have been developed or adapted for
healthcare settings, products, and procedures?
i. What data sources, measures/indicators, and methods are used to
inform these frameworks?
ii. Which components of the frameworks are thought to have the
greatest association with carbon footprint?
iii. What limitations of these frameworks have been described?
GQ2. Studies of LCA
<bullet> How are LCAs applied in healthcare research?
i. What topic areas have been studied and for what settings?
ii. What data sources, measures/indicators, and methods were used
in the analysis?
iii. What outcomes have been studied, and what were the findings?
iv. What were cited limitations of the research?
GQ3. Gaps in the Knowledge and Future Research Needs
<bullet> Are there frameworks that are being developed or have been
developed but not yet implemented?
<bullet> What are possible areas of future research?
Criteria for Inclusion/Exclusion of Studies in the Review
------------------------------------------------------------------------
Domain Inclusion Exclusion
------------------------------------------------------------------------
Population.................. <bullet> GQ1: <bullet>
Publications that Publications citing
include a figure or existing frameworks
detailed without further
description of a conceptual
life cycle contribution to the
assessment framework and
framework. publications
<bullet> GQ2: describing only the
Publications that need or future
describe the plans of conducting
methods and results a life cycle
of a life cycle assessment.
assessment study.
<bullet> GQ3:
Registered research
of life cycle
framework
development or
assessment.
Concept..................... Life cycle <bullet> Frameworks,
assessments that assessments,
address either ongoing research
scope 1, scope 2, not including life
scope 3 emissions. cycle assessments.
Scope 1: Direct
emissions
(facilities,
anesthetics, fleet
and leased
vehicles), Scope 2:
Indirect emissions
(electricity,
stream). Scope 3:
Other indirect
emissions (food and
catering, business
services, medical
devices, medicines,
water, metered-dose
inhalers, energy
[well-to-tank],
business travel
[public transit,
gray fleet], staff
commuting,
manufacturing
[products,
chemicals, gases],
waste, information
technology, Health
Care Organization
(HCO) investments,
construction, and
freight transport).
<bullet> GQ1:
Frameworks for life
cycle assessments,
including logic
models, analytic
frameworks, or
other
conceptualization.
<bullet> GQ2:
Published life
cycle assessments,
life cycle
assessments do not
need to meet ISO
(International
Organization for
Standardization)
14040 standards but
need to describe a
goal, scope, and
boundaries;
assessment can
describe partials
or full cradle to
grave cycles.
<bullet> GQ3:
Ongoing research,
development of
frameworks and
assessments.
Context..................... <bullet> Healthcare: <bullet> Studies in
healthcare delivery contexts not
organizations, specific to
health insurance, healthcare.
or manufacturers/
suppliers that
directly contribute
to the delivery of
healthcare (e.g.,
supply of personal
protective
equipment)
including scope 1,
scope 2, and scope
3 emissions.
Other limiter............... <bullet> Information <bullet> Data
published in reported in
English-language abbreviated format
journal (e.g., conference
manuscripts, trial abstracts) will be
records, and gray excluded;
literature in the systematic reviews
public domain from will be retained
the outlined for reference
sources. mining.
------------------------------------------------------------------------
Abbreviations: GQ guiding questions; HCO health care organization;
ISO International Standards Organization.
Dated: September 26, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-21481 Filed 9-28-23; 8:45 am]
BILLING CODE 4160-90-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.